HSBC Call 35 JEN 19.06.2024/ DE000HG7ARC9 /
03/06/2024 8:26:51 | Diferencia0.000 | Bid13:02:25 | Ask13:02:25 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Volumen de oferta: 25,000 |
0.033 Tamaño/ Volumen/ Formato de Ask: 25,000 |
JENOPTIK AG NA O.N. | 35.00 - | 19/06/2024 | Call |
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
14:15
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
14:14
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
14:10
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
14:04
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
14:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
14:00
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
14:00
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
14:00
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página